Autor: |
Payal Agarwal, Melissa P. Crepps, Natalie A. Stahr, Will P. Kretzschmar, Hannah C. Harris, Nripesh Prasad, Shawn E. Levy, Bruce F. Smith |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Biochemistry and Biophysics Reports, Vol 28, Iss , Pp 101106- (2021) |
Druh dokumentu: |
article |
ISSN: |
2405-5808 |
DOI: |
10.1016/j.bbrep.2021.101106 |
Popis: |
Delay in cancer diagnosis often results in metastasis and an inability to successfully treat the tumor. The use of broadly cancer-specific biomarkers at an early stage may improve cancer treatment and staging. This study has explored circulatory exosomal miRNAs as potential diagnostic biomarkers to identify cancer patients. Secretory exosomal miRNAs were isolated from 13 canine cancer cell lines (lymphoma, mast cell tumor, histiocytic cell line, osteosarcoma, melanoma, and breast tumor) and were sequenced by Next-Generation sequencing (NGS). We have identified 6 miRNAs (cfa-miR-9, -1841, −1306, −345, −132, and −26b) by NGS that were elevated in all cancer cell types. The miRNAs identified by NGS were then examined by Q-RT-PCR. The PCR data demonstrated similar expression patterns to those seen with NGS but provided fold differences that were much lower than those seen for NGS. Cfa-miR-9 was found to be the most consistently elevated miRNA in NGS and PCR, making it the most likely miRNA to prove diagnostic. In this study, we have demonstrated that it is possible to identify exosomal miRNAs with elevated secretion across multiple tumor types that could be used as circulatory diagnostic biomarkers for liquid biopsy in the future. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|